Merck KGaA MRK.DE
Merck KGaA statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€172.82); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Merck KGaA trades at about 23.2× earnings — near its 10-year norm (10-year range 20.9×–25×, median 23.5×).
Shaded band = 10-year range (20.9×–25×); dot = today's 23.2×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 58.5% | 59.0% | 59.0% | 61.6% |
| Operating margin | 17.3% | 18.9% | 17.0% | 21.4% |
| Net margin | 12.4% | 13.1% | 13.5% | 15.0% |
| FCF margin | 9.4% | 11.4% | 8.4% | 11.0% |
| Return on assets | 5.1% | 5.4% | 5.8% | 6.9% |
| Return on equity | 9.1% | 9.3% | 10.6% | 12.8% |
| Debt / equity | 0.36× | 0.21× | 0.33× | 0.34× |
| Current ratio | 1.46 | 1.19 | 1.42 | 1.28 |
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.